AI-Enabled Tech Faces Dual Hurdles in FDA Regulation, Patent Law - Bloomberg Law News

The development of AI-enabled technology faces challenges in FDA regulation and patent law, hindering its growth and adoption in the healthcare sector. The FDA's regulatory framework is struggling to keep pace with the rapid evolution of AI technology, while patent law is creating uncertainty around intellectual property rights. This dual hurdle may slow the pace of innovation in AI-enabled healthcare solutions.